课题基金 / 基金详情

Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial

Addition of high dose Stimulant and engagement-focused Contingency management, alone and in combination, to treatment as usual for the management of MEthamphetamine use disorder (ASCME): a pan-Canadian multisite randomized controlled trial
单独或联合使用高剂量兴奋剂和以参与为重点的应急管理，以照常治疗来治疗甲基苯丙胺使用障碍 (ASCME)：一项泛加拿大多中心随机对照试验
批准号：
459938
负责人：
Jutras-Aswad Didier
金额：
$363.26万
依托单位：
Centre hospitalier de l'Universit de Montral (CHUM)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2022
资助国家：
加拿大
项目状态：
未结题
起止时间：
2022-02-01 至 2026-02-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=459938&lang=en
关键词：
Addiction Agonist Therapy Contingency Management High Dose Stimulant Mental Health Methamphetamine Randomized Clinical Trial

项目摘要

项目成果

Jutras-Aswad Didier的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Methamphetamine ("meth"; MA) use in Canada is on the rise. In the past decade, the number of deaths, hospitalizations, and emergency room visits due to MA and other stimulant use has increased across Canada. MA is highly addictive. Withdrawal symptoms inc
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cannabidiol as a new intervention for cocaine dependence
海外基金